Skip to Content

'
Ju-Seog Lee, PhD

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Systems Biology, Division of Cancer Medicine, UT MDACC, Houston, TX

Education & Training

Degree-Granting Education

1999 University of Texas, Dallas, TX, PHD, Molecular and Cell Biology
1994 University of Texas, Dallas, TX, MS, Molecular and Cell Biology
1988 Kyunghee University, Seoul, Korea, Republic of, BS, Biology

Experience/Service

Academic Appointments

Assistant Professor, Systems Biology, Division of Cancer Medicine, UT MDACC, Houston, TX, 8/2006-8/2012

Other Appointments/Responsibilities

Research Fellow, National Institutes of Health, Bethesda, MD, 10/2005-7/2006
CRTA Fellow, National Institutes of Health, Bethesda, MD, 2001-2005
Graduate Research Assistant, University of Texas at Dallas, Dallas, TX, 1997-1998

Honors and Awards

2009 Waun Ki Hong Award for Excellence in Team Science, UT MD Anderson Cancer Center
2007-2009 V. Scholar Award, V Foundation
2005 Incorporated Scholar-in-Training Award, AACR-AFLAC
2005 Johng S. Rhim Young Investigator Award, Society for Biomedical Research
2004 Fellow Award for Research Excellence, National Institutes of Health
2002 Fellow Award for Research Excellent, National Institutes of Health
2001 Technology Transfer Award, National Cancer Institute

Grant & Contract Support

Title: Prognostic Biomarkers of Colon Cancer
Funding Source: Ventana Medical Systems
Role: Principal Investigator
Duration: 9/1/2014 - 8/31/2015
 
Title: Molecular Determinants and Clinical Implications of Breast Cancer Dormancy
Funding Source: Department of Defense (DOD)
Role: Collaborator
Principal Investigator: Lin
Duration: 9/15/2012 - 9/14/2014
 
Title: Hippo pathway in Hepatocellular Carcinoma
Funding Source: SINF
Role: Principal Investigator
Duration: 9/1/2012 - 8/31/2015
 
Title: Genotyping and Phenotyping of Diffuse Gastric Cancer
Funding Source: Taiho Pharma
Role: Co-Investigator
Principal Investigator: Ajani
Duration: 11/18/2011 - 11/17/2015
 
Title: Validation of prognostic markers in advanced hepatocellular carcinoma and identification of potential serological prognostic markers.
Funding Source: UT MDACC
Role: Principal Investigator
Duration: 8/1/2011 - 7/31/2013
 
Title: Validation of paclitaxel sensitivity associated with silence of Hippo pathway in ovarian cancer
Funding Source: Institute for personalized medicine
Role: Principal Investigator
Duration: 10/1/2010 - 9/30/2011
 
Title: GLIPR1-ATM protein therapy for prostate cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Thompson
Duration: 9/1/2010 - 8/31/2014
 
Title: Hippo pathway as prognostic markers and potential therapeutic targets for colorectal cancer
Funding Source: GS Hogan Foundation
Role: Principal Investigator
Duration: 8/1/2010 - 7/31/2011
 
Title: Characterizing and targeting replication stress response defects in breast cancer
Funding Source: DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
Role: Collaborator
Principal Investigator: Lin
Duration: 7/15/2010 - 7/14/2016
 
Title: Androgenic Regulation of White Adipose Tissue-Prostate Cancer Interactions
Funding Source: Department of Defense (DOD)
Role: Co-Principal Investigator
Principal Investigator: Thompson
Duration: 5/1/2010 - 4/30/2015
 
Title: Development and validation of prognostic model for gastric cancer
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 4/10/2010 - 1/28/2015
 
Title: Multifunctional roles of homeobox gene DLX in ovarian cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Naora
Duration: 4/1/2010 - 3/31/2016
 
Title: Development and validation of prognostic model for gastric cancer
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 4/1/2010 - 3/31/2015
 
Title: Prediction of pathologic complete response by gene expression profiling in esophageal cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Ajani
Duration: 2/1/2010 - 1/31/2015
 
Title: Characterization of bidirectional cellular communication between prostate cancer cells and bones cells during bone metastasis
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 1/1/2010 - 12/31/2011
 
Title: Molecular Markers of Response to Chemoradiation in Localized Esophageal Cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Ajani JA
Duration: 10/1/2008 - 9/30/2010
 
Title: Characterization of gene expession patterns of microenvironment in metastasized osteoblastic prostate cancer
Funding Source: Department of Defense (DOD)
Role: Principal Investigator
Duration: 7/28/2008 - 8/31/2010
 
Title: Systems-level characterization of bidirectional cellular communication between cancer cells and stromal cells during invasion of prostate cancer
Funding Source: Department of Defense (DOD)
Role: Principal Investigator
Duration: 7/28/2008 - 6/30/2010
 
Title: Characterization of microenvironment of breast cancer brain metastasis
Funding Source: V Foundation
Role: Principal Investigator
Duration: 11/1/2007 - 10/31/2009
 
Title: Novel strategy to identify potential therapeutic targets for cancer co-opted stromal cells of breast cancer
Funding Source: UT MDACC
Role: Principal Investigator
Duration: 9/1/2007 - 8/31/2008
 
Title: Validation of preclinical models of human bladder cancer using comparative functional genomics
Funding Source: Bladder Cancer SPORE Pilot Project
Role: Principal Investigator
Duration: 6/1/2007 - 5/31/2009
 
Title: Comparative Functional Genomics of Liver Cancer
Funding Source: 21C Frontier Functional Human Genome Project
Role: Contractor
Duration: 10/1/2006 - 3/31/2010

Last updated: 8/31/2015